08:35 AM EDT, 03/14/2024 (MT Newswires) -- Health care stocks were gaining premarket Thursday with the Health Care Select Sector SPDR Fund (XLV) recently advancing 0.59% while the iShares Biotechnology ETF (IBB) was up 0.4%.

Mirum Pharmaceuticals ( MIRM ) was up 7.1% after the company said that the US Food and Drug Administration has approved its Livmarli product for the treatment of cholestatic pruritus in patients who are at least five years old with progressive familial intrahepatic cholestasis.